会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 63. 发明申请
    • COMPUTER-BASED DIABETES MANAGEMENT
    • 基于计算机的糖尿病管理
    • WO2014074476A1
    • 2014-05-15
    • PCT/US2013/068399
    • 2013-11-05
    • SMARTLOOP LLC
    • MAZLISH, Bryan
    • G06F19/00G06Q50/22
    • A61B5/4866A61B5/14532A61B5/4833A61B5/4839A61B5/4848A61B5/7225A61B5/7246A61B5/7275A61B5/743A61B5/7475G06F19/00
    • A computer-based method includes receiving, from a computer-based user interface, user-specified information about one or more events iniluentiai on the user's blood glucose level, generating, with a computer-based processor, a plurality of estimated trajectories of the user's blood glucose level as influenced by the one or more events, receiving a set of data that represents actual blood glucose measurements for the user, and identifying, with the computer-based processor, which of the estimated trajectories represents a best fit to the set of data that represents the actual biood glucose measurements for the user. At lea st some of the actual blood glucose measurements occurred later in time than a start time of the one or more events influential on the user's blood glucose level. A computer-based system is provided for implementing the method.
    • 基于计算机的方法包括从基于计算机的用户界面接收关于用户血糖水平上的一个或多个事件的用户指定的信息,用基于计算机的处理器生成用户的血糖水平的多个估计的轨迹 由一个或多个事件影响的血糖水平,接收代表用户的实际血糖测量值的一组数据,以及用基于计算机的处理器识别估计的轨迹中哪一个代表最适合于该组 表示用户实际生物体葡萄糖测量的数据。 在一些实际的血糖测量中,一些实时血糖测量发生在比用户血糖水平影响的一个或多个事件的开始时间之后。 提供了一种基于计算机的系统来实现该方法。
    • 68. 发明申请
    • OPTIMIZING MEDICATION DOSAGE BASED ON ANALYTE SENSOR DATA
    • 基于分析仪传感器数据优化药物剂量
    • WO2014036177A1
    • 2014-03-06
    • PCT/US2013/057143
    • 2013-08-28
    • ABBOTT DIABETES CARE INC.
    • SLOAN, Mark, KentFENNELL, Martin, J.BERNSTEIN, Daniel, Milfred
    • A61B5/00A61B5/145
    • A61B5/14532A61B5/4839A61M5/1723A61M2005/14208G06F19/00G06F19/3456G06F19/3468
    • Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.
    • 提供了方法,装置和系统,用于确定是否以单一剂量施用药物剂量,或者是否将作为至少两个离散剂量的单一剂量分配。 实施例包括确定分析物水平的第一分析物水平和第一变化速率; 基于一个或多个预期的后续药物剂量确定初始药物剂量,相对于分析物水平阈值的第一分析物水平和分析物水平相对于变化率阈值的第一变化速率; 施用初始药物剂量; 基于随后的分析物数据确定分析物水平的第二分析物水平和第二变化速率; 以及基于相对于所述分析物水平阈值的所述第二分析物水平和相对于所述变化率阈值的所述第二变化率来确定随后的药物剂量。